Mandatory Notification of Trade - Hjelmaas
(Oslo, Norway, 26 September 2016) Reference is made to the announcement on 14 September 2016 regarding the Rights Offering in Bionor Pharma ASA (the “Company”).
STOCK EXCHANGE ANNOUNCEMENT
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES
Primary insider notification – Unni Hjelmaas
Unni Hjelmaas, a primary insider of the Company, has on Friday 23 September 2016 purchased through her wholly owned company, Hjelmaas AS, 400,000 Subscription Rights at NOK 0.10 per Subscription Right and immediately thereafter exercised 400,000 Subscription Rights at NOK 0.10 per Share.
Following such transaction holds the following interests in the Company:
in the Rights Issue
Unni Hjelmaas through
Unni Hjelmaas, Acting CEO, +47 915 19 651, email@example.com
Jens Krøis, CFO, +45 208 01 668, firstname.lastname@example.org
Link to announcement in pdf